Enoxaparin-sodium: Intracranial haemorrhage: case report.

In a retrospective cohort study, a patient with primary central nervous system malignancies and secondary unspecified metastases developed intracranial hemorrhage (ICH) while receiving anticoagulant therapy with enoxaparin-sodium. The patient's therapy with enoxaparin-sodium was discontinued. The study did not provide specific details about the patient's age, sex, dosage, route of administration, time to reaction onset, or outcome. [Extracted from the article]

Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)